[PDF] Top 20 Villa-Lobos: Música e Nacionalismo na República Velha
Has 10000 "Villa-Lobos: Música e Nacionalismo na República Velha" found on our website. Below are the top 20 most common "Villa-Lobos: Música e Nacionalismo na República Velha".
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism
... by rivaroxaban (bypassing the need for new synthesis of coagulation factors) mean that minor bleed- ing can often be controlled by temporary or permanent discontinuation of ... See full document
73
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
... favorable pharmacokinetic characteristics with a bioavailability of ...60%–80%. Rivaroxaban achieves peak plasma levels in three hours and has a half-life of nine hours in healthy, young subjects and about ... See full document
5
The diagnosis and treatment of venous thromboembolism in Asian patients
... apixaban, rivaroxaban, low-dose unfractionated heparin, vitamin K antagonist (VKA; ie, warfarin), or aspirin, for patients undergoing major orthopedic surgery of the lower limbs, such as total hip or knee ... See full document
32
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
... [10,11]. Rivaroxaban was non-inferior to standard treat- ment and was associated with a reduced incidence of major bleeding ...the rivaroxaban group during the initial treatment phase ... See full document
67
Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients
... placebo (95% CI 1.52–5.60), with numerically more patients in the dabigatran group with major bleeding (two versus none). Rivaroxaban also had a 5.19-fold increase in first major or clinically relevant nonmajor ... See full document
5
Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations
... of venous thromboembolism, manifesting as deep vein thrombosis or pulmonary ...pharmacologic treatment options for thromboprophylaxis after major orthopedic surgery include the vitamin K antagonists ... See full document
7
Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist
... with rivaroxaban than with standard therapy, irrespective of indication and treatment ...duration. Rivaroxaban was associated with per-patient cost savings for each treatment duration modelled ... See full document
6
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
... Both studies used the same protocol to ascertain out- comes. Patients were followed for the intended treatment period and assessed at fixed intervals that were identical in the two treatment groups [8,9]. ... See full document
6
Prevention and treatment of venous thromboembolism during HRT: current perspectives
... Abstract: Many large trials in the past 15 years have proven an increased risk of vascular complications in women using oral, mostly non-bioidentical, hormone therapy. The risk of vascular complications depends on the ... See full document
8
Review Article Rivaroxaban decreases recurrent venous thromboembolisms in patients with deep vein thrombosis: a meta-analysis
... A total of 11 RCTs were included in this pooled analysis. Table 1 lists the main characteristics of these 11 RCTS. These studies were multi- center trials ranging from 2008 to 2015. Clinical follow-up course ranged from ... See full document
127
New anticoagulants for the prevention of venous thromboembolism
... anticoagulant treatment and prophy- laxis easier as they are mostly available for oral administra- tion in fixed doses, have short half-lives, and rapid onset of ...and pharmacokinetic properties, the new ... See full document
14
Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
... as venous thromboembolism ...dabigatran, rivaroxaban, apixaban, edoxaban) in clinical trials testing these new compounds in the acute/ long-term and extended therapy of VTE, providing subgroup ... See full document
46
Overview of guidelines for the prevention and treatment of venous leg ulcers: a US perspective
... In the US, manual lymphatic drainage is provided by physical or occupational therapists in an outpatient rehabilita- tive setting. Many of these patients with significant chronic venous insufficiency and even ... See full document
8
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
... only ~30%, well within its therapeutic window [4]. In addition, the half-life of rivaroxaban increases by only ~1 h in patients with severe renal impairment, indicating a limited potential for drug accumulation ... See full document
86
New anticoagulants for the prevention and treatment of venous thromboembolism
... The balance between normal hemostasis and thrombosis is determined by the interaction of numerous individual pro- and anticoagulant factors, increased knowledge of which has enabled identification of novel therapeutic ... See full document
8
Update on the clinical use of the low-molecular-weight heparin, parnaparin
... and treatment of venous thromboembolism (VTE), and for the treatment of acute coronary syndromes (ACS) and peripheral arterial occlusive disease (PAOD), and for the management of chronic ... See full document
17
High prevalence of antinuclear antibodies in patients following venous thromboembolism
... is considered to be “provoked” in the presence of a tempo- rary or reversible risk factor (such as surgery, trauma, im- mobilization, pregnancy, oral contraceptive use or hormone replacement therapy) within the last 6 ... See full document
7
Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
... of treatment did not differ between apixaban and control treatments (Table 3), and that no excess myocardial infarction, stroke, or any serious adverse event was observed with apixaban during the overall study ... See full document
8
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice
... of venous thromboembolism after major orthopedic surgery has been subcutaneous low-molecular-weight ...anticoagulant rivaroxaban has demonstrated superior efficacy and similar safety to all tested ... See full document
23
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
... drug evaluation should take into account PK, and in some (specific) cases PD studies with single or multiple doses (when reaching a steady-state level is deemed ...PK evaluation, the existence of actual ... See full document
14
Related subjects